The White House said Medicaid programs in all 50 states, D.C. and Puerto Rico now receive MFN prices, with nearly $65 billion in savings over a decade.
|Articles|March 3, 2014
- Pharmaceutical Commerce - March/April 2014
CMS posts Sunshine Act registration details
Advertisement
On Feb. 7, CMS posted a notice that it will begin accepting registrations for Sunshine Act aggregate-spending reports from industry on Feb. 18.
Articles in this issue
over 12 years ago
The pharma rep profession will be immortalover 12 years ago
Six factors driving new specialty pharmaciesover 12 years ago
Common misconceptions about the orphan drug designationover 12 years ago
So you are 'in the cloud;' now what?over 12 years ago
Network effect of industry-crowdsourced physician dataover 12 years ago
Make your CRM vendor a true partner to your sales teamover 12 years ago
New adverse-events reporting service speeds results to payersover 12 years ago
Acquisitions realign UK logistics services, cold chain packagingover 12 years ago
After a relatively flat year, 2014 could be big for pharma M&AAdvertisement
Related to this article
Rebate delays could force 340B hospitals to pay upfront and wait months for credit, distorting drug spend on the books. Valerie Bandy, PharmD, of Tecsys explains the fallout.
In this week's Pharma Pulse, Arkansas independent pharmacies bring an underpayment suit against Express Scripts, Novo Nordisk taps Anthropic for AI-driven drug discovery, and Sanofi, UCB and Opella join AstraZeneca on a supply chain heat decarbonization program.
DSCSA data exchange has matured into daily operations, but the coming NDC-12 shift and a national licensure standard add new work streams before old ones are fully settled.
As HRSA's 340B Rebate Model Pilot moves toward its effective date, Valerie Bandy, PharmD, of Tecsys explains what drug-by-drug rebate tracking really demands from hospital and health system pharmacies.
Authenticx CEO Amy Brown on why patient support AI needs continuous oversight, not just adoption.
HDA's Kala Shankle unpacks the biggest open question on preemption and offers a two-step playbook for wholesalers and 3PLs preparing for national licensure.
In this week's Pharma Pulse, DHL breaks ground on a new cold chain hub at Singapore's Changi Airport, a new report finds pharma's commercial model in the middle of a fundamental reset, and the FDA grants accelerated approval to sevabertinib.
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
White House Extends MFN Pricing to Every State Medicaid Program
2
Pharma Pulse: Independent Pharmacies Sue Express Scripts, Novo Taps Anthropic, Pharma Joins Clean Heat
3
What 340B Rebate Tracking Really Demands From Pharmacies
4
How Rebate Timing Distorts a Pharmacy's 340B Books
5